Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cayey, PR
NPI
1487053385
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
109 Ave Jose de Diego E
Cayey, PR, 00736
Phone (787) 366-0634
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,677
36 services
Medicare patients, 2024
13
Average age 75
Drug cost, 2024
$2.9M
5,501 prescriptions
Company payments, 2025
$593
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anardi A Agosto Mujica was code 99213 (office e&m - established), 22 times for 11 patients. In total Anardi A Agosto Mujica billed 36 services in 8 codes, and Medicare paid $2,677.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 22 | 11 | $64.10 | $1,410 |
By year: 2022 $3,712 for 49 services; 2023 $2,310 for 37 services; 2024 $2,677 for 36 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anardi A Agosto Mujica prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 704 prescriptions and refills. In total Anardi A Agosto Mujica wrote 5,501 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 704 | 1,678 | 210 | $72K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 328 | 616 | 96 | $364K |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 322 | 562 | 85 | $427K |
| Ozempic Semaglutide | 245 | 380 | 72 | $271K |
| Rosuvastatin Calcium Generic | 241 | 687 | 100 | $3,994 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 226 | 260 | 65 | $19K |
| Trulicity Dulaglutide | 221 | 417 | 53 | $422K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 221 | 304 | 51 | $148K |
| Metformin Hcl Generic | 215 | 603 | 83 | $2,001 |
| Atorvastatin Calcium Generic | 200 | 572 | 79 | $2,774 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 189 | 373 | 63 | $217K |
| Glipizide Generic | 153 | 447 | 48 | $2,641 |
| Farxiga Dapagliflozin Propanediol | 149 | 321 | 52 | $184K |
| Synjardy Empagliflozin/Metformin Hcl | 131 | 216 | 42 | $127K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 110 | 185 | 29 | $13K |
Brand drugs: 3,532 claims; generic drugs: 1,689 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anardi A Agosto Mujica $593 ($593 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $568.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.